News . Data . Research
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) Q4 2021 earnings call dated Feb. 17, 2022 Corporate Participants: Matt Roach -- Director of Investor Relations Thomas McCourt -- Chief Executive
10X Genomics Inc. (NASDAQ: TXG) Q4 2021 earnings call dated Feb. 16, 2022 Corporate Participants: Eric Jaschke -- Director Investor Relations and Strategic Finance
Meihua International Medical Technologies is the latest healthcare company to seek Wall Street listing, even as the IPO market picks up momentum
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q4 2021 earnings call dated Feb. 15, 2022 Corporate Participants: Atabak Mokari -- Chief Financial Officer Charles Robb -- Chief Business
Zoetis Inc. (NYSE: ZTS) Q4 2021 earnings call dated Feb. 15, 2022 Corporate Participants: Steve Frank -- Investor Relations Kristin Peck -- Chief Executive Officer Wetteny
IQVIA Holdings, Inc. (NYSE: IQV) Q4 2021 earnings call dated Feb. 15, 2022 Corporate Participants: Nicholas Childs -- Senior Vice President, Investor Relations and
Aurora Cannabis Inc. (NYSE: ACB) Q2 2022 earnings call dated Feb. 10, 2022 Corporate Participants: Ananth Krishnan -- Vice President- Strategic Finance Miguel Martin -- Chief
Illumina, Inc. (NASDAQ: ILMN) Q4 2021 earnings call dated Feb. 10, 2022 Corporate Participants: Salli Schwartz -- Vice President of Investor Relations Francis deSouza -- Chief
Canopy Growth Corporation (NASDAQ: CGC) Q3 2022 earnings call dated Feb. 09, 2022 Corporate Participants: Tyler Burns -- Director, Investor Relations David Klein -- Chief Executive
CVS Health Corporation (NYSE: CVS) reported fourth-quarter 2021 earnings results today. Total revenues increased 10% year-over-year to $76.6 billion. Net income attributable
Centene Corporation (NYSE: CNC) Q4 2021 Earnings Call dated Feb. 08, 2022 Corporate Participants: Jennifer Gilligan -- Senior Vice President, Finance and Investor Relations
Pfizer Inc. (NYSE: PFE) Q4 2021 earnings call dated Feb. 08, 2022 Corporate Participants: Chris Stevo -- Senior Vice President and Chief Investor Relations
Pfizer Inc. (NYSE: PFE) reported fourth quarter 2021 earnings results today. Revenues doubled year-over-year to $23.8 billion. Excluding contributions from Comirnaty and
The biomedical industry grew at an accelerated pace in 2021 even as healthcare systems went into overdrive amidst the COVID-induced medical emergency.
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q4 2021 earnings call dated Feb. 04, 2022 Corporate Participants: Mark Hudson -- Director, Investor Relations Leonard S. Schleifer -- Founder,
Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2021 earnings results today. Total revenues increased 8% year-over-year to $12 billion, driven by
Merck & Co., Inc. (NYSE: MRK) Q4 2021 earnings call dated Feb. 03, 2022 Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations
Cigna Corporation (NYSE: CI) Q4 2021 earnings call dated Feb. 03, 2022 Corporate Participants: Ralph Giacobbe -- Investor Relations David Cordani -- Chairman and Chief Executive
Eli Lilly and Company (NYSE: LLY) Q4 2021 earnings call dated Feb. 03, 2022 Corporate Participants: Kevin Hern — Investor Relations David A. Ricks — Chair
Biogen, Inc. (NASDAQ: BIIB) Q4 2021 earnings call dated Feb. 03, 2022 Corporate Participants: Michael Hencke -- Head of Investor Relations Michel Vounatsos -- Chief Executive
Cardinal Health, Inc. (NYSE: CAH) Q2 2022 earnings call dated Feb. 03, 2022 Corporate Participants: Kevin Moran -- Vice President of Investor Relations Mike